High dividend yields can be a warning sign for investors. Yields generally correlate negatively with stock price movements, after all,…
JCI boosts the AI capabilities in its OpenBlue Enterprise Manager suite, introducing generative AI applications, improved building controls and an…
…
…
If approved, daratumumab will become the first treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple…
PARSIPPANY, NJ – November 7, 2024, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lincoln Educational Services Corporation (NASDAQ: LINC),…
JCIs fiscal fourth-quarter results benefit from strength in the HVAC & controls businesses.…
The company exceeded analyst projections on both its top and bottom lines in its latest completed quarter.…
Kate Johnson, Lumen CEO, joins Closing Bell: Overtime to discuss the companys tech partnerships, Google Cloud deal and AI.…
mazon.com, Johnson & Johnson, Boston Scientific and Armanino Foods of Distinction are part of the Zacks top Analyst Blog.…
Todays Research Daily features new research reports on 12 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and…
…
Johnson & Johnson (NYSE:JNJ) researches, develops, manufactures and sells various products in the health care field worldwide. It is set…
Fewer contenders means fewer constraints on expanding market share.…
Fewer contenders means fewer constraints on expanding market share.…
Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…
Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi are included in this Analyst Blog.…
Starboard Value has amassed a significant stake in Kenvue, which spun out of Johnson & Johnson in mid-2023.…
New York (www.aktiencheck.de) - Rating-Update:
Joanne Wuensch, Analystin der Citigroup, bewertet die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN:…
Kaum ein Unternehmen schüttet so sicher Dividenden aus wie Johnson & Johnson. Und seit 62 Jahren steigen sie kontinuierlich und…
Investigation underway into leak of US intelligence on Israel-Iran, Houses Johnson says…
…
Toronto (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von RBC Capital Markets:
Rating und Kursziel
RBC Capital Markets hat das Kursziel für Johnson &…
…
Johnson & Johnsons latest financial checkup shows its still in excellent health.…
New York (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Morgan Stanley:
Morgan Stanley erhöht Kursziel auf 175 USD
Der Analyst Terence Flynn von…
Johnson & Johnson infused positive optimism after posting solid third-quarter 2024 earnings. A few analysts raised their target price on…
People who voted to settle their baby power-related health claims against Johnson & Johnson should have their ballots thrown out…
Am US-amerikanischen Aktienmarkt ist der Anteilsschein von Johnson & Johnson aktuell unauffällig. Das Papier kostete zuletzt 164,46 US-Dollar. Kaum auffällig…
Der Pharma- und Medizintechnikhersteller Johnson & Johnson (JNJ) hat am Dienstag, den 15. Oktober 2024 seine Geschäftszahlen für das…
St. Louis (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Stifel:
Stifel hat das Kursziel für Johnson & Johnson (ISIN: US4781601046, WKN: 853260,…
San Francisco (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Wells Fargo Advisors:
Wells Fargo hat das Kursziel für Johnson & Johnson (ISIN:…
JNJ earnings call for the period ending September 30, 2024.…
…
…
Bank of America (BAC), Goldman Sachs (GS), Johnson & Johnson (JNJ) and UnitedHealth (UNH) are the stocks to watch on…
US stock futures (ES=F, NQ=F, YM=F) are flat Tuesday morning coming off the Dow Jones Industrial Average (^DJI) and S&P…
Johnson & Johnson (NYSE:JNJ) shares moved higher after the pharmaceutical giant posted better-than-expected results for the third quarter. Earnings per...…
…
Die Berichtssaison in den USA nimmt peu à peu an Fahrt auf. Traditionell gehört Johnson & Johnson neben den großen…
NEW BRUNSWICK (dpa-AFX) - Wegen der Übernahme eines Medizingeräte-Entwicklers wird der operative Gewinn des Pharma- und…
Johnson & Johnson reports Q3 beat, raises sales guidance…
Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and Magic…
United Health, Johnson & Johnson lead Tuesdays earnings lineup…
Analysts are feeling more optimistic about Johnson Controls, Albemarle, and Owens Corning.…
Analysts are feeling more optimistic about Johnson Controls, Albemarle, and Owens Corning.…
Charles Schwab, Bank of America, Johnson & Johnson, Walgreens, UnitedHealth Group Morgan Stanley, Procter & Gamble and Abbott Laboratories all…
…
SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP (www.johnsonfistel.com), a shareholder rights law firm, announces…
Johnson & Johnson said it will discontinue a mid-stage field study evaluating the efficacy of its experimental pill for the…